Hsinchu, Taiwan

Chi-ming Lee

This inventor holds 1 USPTO granted patent. Top assignees: Cancer Free Biotech Ltd., Songyi System Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chi-ming Lee. Retrieved from https://idiyas.com/inventor/chi-ming-lee-nxzpwtt9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chi-ming Lee and Automated Liquid-Sample Processing

Introduction

Chi-ming Lee is an inventor associated with Hsinchu, Taiwan. His work includes an invention designed to automate the handling and processing of liquid samples.

Latest Patents

Lee is credited with 1 patent: “Automatic Processing Device for Liquid Samples.” The device includes a sample region that holds multiple centrifuge tubes, a control module with a mechanical module, an image identification device, and a centrifuge. The mechanical module can loosen or tighten tube caps and transfer liquid into or out of the tubes. The image identification device and centrifuge are coupled to the control module, while the centrifuge accommodates the tubes and performs centrifugal treatment.

Career Highlights

Lee is associated with Cancer Free Biotech Ltd. and Songyi System Co., Ltd. His patent describes an integrated approach to automating several steps in liquid-sample processing.

Collaborations

Lee’s listed coworkers include Po-Han Chen and Chun-chieh Chiang.

Conclusion

Chi-ming Lee’s patent brings tube handling, liquid transfer, image identification, and centrifugation together in an automated device for processing liquid samples.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…